Oral hexavalent reassortant rotavirus attenuated live vaccine

BIOLOGICAL2 trials

Sponsors

Sinovac Life Sciences Co., Ltd.

Conditions

Rotavirus Gastroenteritis

Phase 1

The Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

CompletedNCT06950645

Sinovac Life Sciences Co., Ltd.Rotavirus Gastroenteritis

Start: 2024-03-27End: 2025-12-18Updated: 2026-03-20

Phase 2

PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

RecruitingNCT06967272

Sinovac Life Sciences Co., Ltd.Rotavirus Gastroenteritis

Start: 2025-01-20End: 2026-11-15Target: 400Updated: 2025-08-22